The abstract is read at the publisher; the summary is JClub's.
A single neonatal allele-specific antisense oligonucleotide prevents hippocampal pathology and rescues behavioral deficits in Gria1-A636T knock-in mice modeling GRIA1 p.A636T ASD/ID.
- Why it matters: GRIA1 p.A636T is linked to ASD/ID, but how it disrupts development and whether targeted RNA silencing can reverse resulting hippocampal damage and behavior deficits is unclear.
- What they did: In Gria1-A636T knock-in mice, the mutant transcript was selectively silenced using an allele-specific antisense oligonucleotide delivered once at the neonatal stage.
- The result: The treatment prevents progressive dendritic atrophy and neuronal loss and rescues core ASD/ID-like behaviors, supporting RNA-targeted precision therapy for AMPAR-related neurodevelopmental disorders.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.